关于饮食在性结肠炎中的作用的系统审查
Nasir Abbas1, Mahrukh Shakil2, Zeeshan Akhtar Rana3
1Trauma and Emergency, Combined Military Hospital, Sialkot, PAK.
Cureus
|June 23, 2023
概括
低FODMAP,地中海和抗炎饮食等饮食干预措施对治疗性结肠炎 (UC) 症状和改善生活质量有希望. 个性化的营养计划是有效的UC管理的关键.
科学领域:
- 胃肠病学 胃肠病学
- 临床营养学 临床营养学
- 炎症性肠道疾病研究研究
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症状况,影响结肠和直肠.
- 饮食显著影响UC症状严重程度和管理与医疗治疗一起.
研究的目的:
- 审查当前关于性结肠炎饮食干预措施的研究.
- 确定可以缓解UC症状并提高患者生活质量的特定饮食.
主要方法:
- 在PubMed,在线威利图书馆和谷歌学者中进行了全面的文献搜索.
- 审查的重点是2010年至2023年间发表的临床试验和随机对照试验,特别是检查UC和饮食.
主要成果:
- 一些饮食干预措施,包括低FODMAP饮食,地中海饮食和抗炎饮食,表明了潜在的益处.
- 这些饮食与UC症状的改善和患者的整体生活质量有关.
结论:
- 饮食干预可以成为治疗性结肠炎的重要组成部分.
- 量身定制的饮食策略与其他治疗相结合,对于改善患者的治疗结果至关重要. 需要进一步的研究来优化这些干预措施.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
360
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
360
Drugs for Treatment of Ulcerative Colitis in IBD
179
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179
Inflammatory Bowel Disease I: Ulcerative Colitis
226
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
226
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
469
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
469
Inflammatory Bowel Disease V: Surgical Management
173
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
173
Peptic Ulcer Disease II: Pathophysiology
564
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
564


